| Name | Title | Contact Details |
|---|
CenterLight Health System ranks among the nation`s leading resources for long-term residential and community-based health care. A voluntary, nonprofit organization, CenterLIght has made life better for tens of thousands of New Yorkers from all backgrounds and walks of life. It first opened its doors to the poor, chronically ill and disabled just after the First World War.
Joel Kaplin Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hollister Incorporated is an independently-owned global company that develops, manufactures and markets healthcare products, servicing over 90 countries. From the earliest days of our company, there has been a strong sense of community—a connection to people. That connection is embedded in the very fabric of our company, and as we continue to develop new products and services, we are focused on meeting the healthcare needs of people throughout the global community.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches designed to enable the body`s immune system to fight disease. The company`s technologies are engineered to activate the immune system`s natural ability to create tumor-specific cytotoxic T cells to fight cancer and other chronic disease. Immune Design`s clinical programs are the product of its two synergistic platforms: DCVexTM and GLAASTM.